Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.
Ontology highlight
SUBMITTER: Cunningham D
PROVIDER: S-EPMC5337626 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA